NRX Pharmaceuticals (NRXP) Interest Coverage Ratio (2017 - 2026)

NRX Pharmaceuticals' (NRXP) quarterly Interest Coverage Ratio came in at 20.35 in Q1 2026, up 4.41% on a QoQ basis from 21.29 in Q3 2025.

NRX Pharmaceuticals (NRXP) Interest Coverage Ratio (2017 - 2026) Analysis & Trends

NRX Pharmaceuticals (NRXP) has 8 years of Interest Coverage Ratio data on file, last reported at 20.35 in Q1 2026.

On a quarterly basis, Interest Coverage Ratio changed N/A year-over-year to 20.35 in Q1 2026; TTM through Mar 2026 was 73.48, a 104.01% decrease from a year earlier, with the FY2025 full-year figure at 0.32, up 14.94% from the prior year.
Interest Coverage Ratio for Q1 2026 stood at 20.35, up from 21.29 in the prior quarter.
Over the last five years, Interest Coverage Ratio for NRXP reached as high as 3.88 in Q4 2022 and fell as low as 178.0 in Q2 2023.
Historically, Interest Coverage Ratio has averaged 40.09 across 5 years, with a median of 21.29 in 2025.
On a YoY basis, Interest Coverage Ratio climbed as much as 99.99% in 2022 and fell as far as 6526.46% in 2022.
Year by year, Interest Coverage Ratio stood at 3.88 in 2022, then plunged by 1319.76% to 55.08 in 2023, then soared by 70.88% to 16.04 in 2024, then slumped by 32.76% to 21.29 in 2025, then grew by 4.41% to 20.35 in 2026.
Per Business Quant data, the three most recent Interest Coverage Ratio figures were 20.35 in Q1 2026, 21.29 in Q3 2025, and 16.04 in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	658.42
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	7.60
4	NuCana	279.75 Bn	279.75 Bn	-	-0.22
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	2.71
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	22.72
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-0.38
10	NRX Pharmaceuticals	137.57 Mn	130.87 Mn	437,000.00	-20.35

Download Data